Our look is new. Our purpose is the same. Learn more about our brand evolution.
Our look is new. Our purpose is the same. Learn more about our brand evolution.
GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD.  The goal of the new agreement is to develop a small-molecule-based medicine to potentially reverse FSHD
